Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Androgen-driven traits don't predict prostate cancer recurrence.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

A-PRF+ improves bone healing and stability in oral surgery.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Finasteride reduces prostate size, improves urination, and slows prostate cancer progression.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Injecting Platelet-Rich Plasma reduces leakage risk in colorectal surgery.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Finasteride reduces blood loss and the need for blood transfusions during and after TURP surgery.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

TURP specimens should be checked for various tumors, not just common prostate issues.

Finasteride reduces bleeding during prostate surgery.

New BPH treatments have low sexual dysfunction risk but may not improve urinary symptoms as much as traditional surgery.

Finasteride, a drug that prevents testosterone conversion, can effectively reduce blood loss in prostate surgery, especially for patients with a prostatic volume over 30 cc, and decrease post-surgery complications.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Older patients sticking to their prostate medication saw lasting health benefits.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

Prostate surgery is often effective long-term, but some patients may need more treatment or another surgery, especially if they had prostatitis before.